Literature DB >> 17848854

A pilot study testing the effect of different levels of financial incentives on weight loss among overweight employees.

Eric A Finkelstein1, Laura A Linnan, Deborah F Tate, Ben E Birken.   

Abstract

OBJECTIVE: To test the ability of two levels of modest financial incentives to encourage weight loss among overweight employees.
METHODS: This study used a randomized design with measurements at baseline, 3, and 6 months and two levels of financial incentives ($7 and $14 per percentage point of weight lost). Payments were structured so that all participants had equal ability to obtain the incentives during the study period.
RESULTS: At 3 months, participants with no financial incentive lost 2 pounds, those in the $7 group lost approximately 3 pounds, and those in the $14 group lost 4.7 pounds. Between baseline and 6 months, when the financial gains were equalized, weight losses were similar across groups.
CONCLUSION: This study revealed that modest financial incentives can be effective in motivating overweight employees to lose weight.

Entities:  

Mesh:

Year:  2007        PMID: 17848854     DOI: 10.1097/JOM.0b013e31813c6dcb

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  42 in total

1.  Medicaid Incentives for Preventing Chronic Disease: Effects of Financial Incentives for Smoking Cessation.

Authors:  Allison Witman; Joseph Acquah; Maria Alva; Thomas Hoerger; Melissa Romaire
Journal:  Health Serv Res       Date:  2018-06-12       Impact factor: 3.402

2.  Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association.

Authors:  Dariush Mozaffarian; Ashkan Afshin; Neal L Benowitz; Vera Bittner; Stephen R Daniels; Harold A Franch; David R Jacobs; William E Kraus; Penny M Kris-Etherton; Debra A Krummel; Barry M Popkin; Laurie P Whitsel; Neil A Zakai
Journal:  Circulation       Date:  2012-08-20       Impact factor: 29.690

3.  Obesity coverage gap: Consumers perceive low coverage for obesity treatments even when workplace wellness programs target BMI.

Authors:  Elizabeth Ruth Wilson; Theodore K Kyle; Joseph F Nadglowski; Fatima Cody Stanford
Journal:  Obesity (Silver Spring)       Date:  2017-01-07       Impact factor: 5.002

Review 4.  A Scoping Review of Behavioral Economic Interventions for Prevention and Treatment of Type 2 Diabetes Mellitus.

Authors:  Jeffrey T Kullgren; Dina Hafez; Allison Fedewa; Michele Heisler
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

Review 5.  Effectiveness of Workplace Weight Management Interventions: a Systematic Review.

Authors:  Yasoma Kumari Weerasekara; Susan B Roberts; Mira A Kahn; Amy E LaVertu; Ben Hoffman; Sai Krupa Das
Journal:  Curr Obes Rep       Date:  2016-06

Review 6.  Financial incentives and weight control.

Authors:  Robert W Jeffery
Journal:  Prev Med       Date:  2011-12-29       Impact factor: 4.018

7.  Perceived Self-Efficacy and Financial Incentives: Factors Affecting Health Behaviors and Weight Loss in a Workplace Weight Loss Intervention.

Authors:  Pouran D Faghri; Julia Simon; Tania Huedo-Medina; Amy Gorin
Journal:  J Occup Environ Med       Date:  2017-05       Impact factor: 2.162

8.  Individual- versus group-based financial incentives for weight loss: a randomized, controlled trial.

Authors:  Jeffrey T Kullgren; Andrea B Troxel; George Loewenstein; David A Asch; Laurie A Norton; Lisa Wesby; Yuanyuan Tao; Jingsan Zhu; Kevin G Volpp
Journal:  Ann Intern Med       Date:  2013-04-02       Impact factor: 25.391

9.  "All the money in the world …" patient perspectives regarding the influence of financial incentives.

Authors:  Heather Schacht Reisinger; Rachel Horner Brackett; Colin D Buzza; Monica B Williams Páez; Ryan Gourley; Mark W Vander Weg; Alan J Christensen; Peter J Kaboli
Journal:  Health Serv Res       Date:  2011-06-20       Impact factor: 3.402

10.  Patient opinions regarding 'pay for performance for patients'.

Authors:  Judith A Long; Marie Helweg-Larsen; Kevin G Volpp
Journal:  J Gen Intern Med       Date:  2008-07-29       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.